Congratulations! Very inspiring!

WBC >70K (but not IKZF1plus) increases risk of relapse with blina+ponatinib in Ph+ ALL, particularly extramedullary/CNS. Pts with high WBC should be considered for systemic MTX/Ara-C and/or CAR T-cell consolidation jhoonline.biomedcentral.com/articles/10.11… #leusm #ALL

This is very interesting! Have you looked at day 100 absolute lymphocyte count ?𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM Arjun D. Law

Excited to share with all our latest work on the use of single cell tools in following IDH mutant AML patients during their treatment! Out today Cell Stem Cell !! An amazing collaboration with AK Eisfeld & Elli Papaemmanuil, PhD & Dan Landau !!! Driven by the impressive Maria Sirenko

Delighted to share that ive joined the dept of clinical hematology & medical oncology at PGIMER, Chandigarh as Assistant Professor. A dream come true. Indebted to Pankaj Malhotra for the mentorship and support Excited to continue to serve the people and hopefully do meaningful research

John Ralston Saul, renowned novelist and former president of PEN International, was diagnosed with myelodysplastic syndrome (MDS). Hours after his stem cell transplant at UHN’s Princess Margaret Cancer Centre, he began a new chapter in his life. Read John’s story here: uhn.ca/corporate/news…

Congratulations Charanpreet Singh ! Great news for the department!

#ASCO25 |||| #Brexucabtagene autoleucel (Brexu-cel) as consolidation treatment in adults with B-cell acute lymphoblastic leukemia. | Dr Khaire & ⁦Nitin Jain⁩ ⁦ASCO⁩ #endcancer #leusm ⁦Niranjan Khaire⁩ ascopubs.org/doi/10.1200/JC…

At the #HemOnc poster session at #ASCO25, we spoke with Niranjan Khaire, who presented data on brexu-cel as consolidation treatment in adults with B-ALL. Watch below👇👇 ASCO #Leusm #ALLsm

CONGRESS | #ASCO25 | POSTER Niranjan Khaire (Niranjan Khaire), MD Anderson Cancer Center, presents real-world outcomes from a study of brexucabtagene autoleucel as consolidation treatment in adults with B-ALL. N=52. 12 months RFS and OS were 65% and 90%, respectively. Manageable AEs with

Thank you Ruah Alyamany | روى اليماني

Well done ! Well deserved! What was the abstract?

👉👉👉Wonderful to attend our Thirteenth Annual Leukemia Fellowship Graduation 👨‍🎓 to celebrate our amazing MD Anderson Cancer Center Leukemia Fellows !! Hagop Kantarjian,MD G Garcia-Manero Tapan Kadia #leusm #endcancer

Well deserved ! Congratulations!! Your work has always stimulated and inspired me from afar!

Wow ! Well done Urmi! Congratulations!

It saddens and surprises me to see this - A legend Hagop Kantarjian,MD who has changed how we approach leukemia forever is stepping down. A blog by Leonard Zwelling just out. lenzwelling.com/2025/06/an-emb…

🚨 New paper in Nature Genetics ! How does cancer chemotherapy reshape the HSC landscape and drive the evolution of therapy-related myeloid neoplasms? We uncovered this process through single-colony WGS! See the full paper here! nature.com/articles/s4158…

Excited to embark on this journey together in the Leukemia Fellowship MD Anderson Cancer Center OncoDaily #LeukemiaFellowship #makingcancerhistory #Hematology #malignantheme

Welcome friends!

CONGRESS | #SOHO2025 | POSTER Niranjan Khaire MD Anderson Cancer Center shares findings from a retrospective real-world analysis of the efficacy and toxicity of brexucabtagene autoleucel consolidation, in adult patients with B-cell ALL with <5% marrow blasts (N = 52). Brexu-cel was